Mathematical models and cost-effective screening strategies for colorectal cancer

CMAJ. Canadian Medical Association Journal

Volumn 182, Issue 12, 2010, Pages 1283-1284

  Smith, Robert A ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DNA DETERMINATION; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; MATHEMATICAL MODEL; NOTE; OCCULT BLOOD TEST; SIGMOIDOSCOPY; COLORECTAL NEOPLASMS; COST; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; MASS SCREENING; OCCULT BLOOD; THEORETICAL MODEL;

COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; HUMANS; MASS SCREENING; MODELS, THEORETICAL; OCCULT BLOOD;

EID: 77956412804     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.100986     Document Type: Note

References (10)

1. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
2. Byers T, Levin B, Rothenberger D, et al. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 1997;47:154-60. (Pubitemid 27226282)
3. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
4. Telford JJ, Levy AR, Sambrook JC, et al. The cost-effectiveness of colorectal cancer screening in Canada. CMAJ 2010;182:1307-13.
5. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force. Ann Intern Med 2008;149:659-69.
6. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14.
7. Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207-17.
8. Campbell H, Briggs A, Buxton M, et al. The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm. J Health Serv Res Policy 2007;12:11-7. (Pubitemid 46174200)
9. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:1253-8.
10. Box GEP, Draper NR. Empirical model-building and response surfaces. New York (NY): Wiley; 1987.